Implementation of medication management services at the primary healthcare level - a pilot study

Andrea Brajković, Iva Mucalo, Toni Vidović, Mariana Martins Gonzaga, Do Nascimento, Antonija Balenović, Ino Protrka, Djenane Ramalho De Oliveira, Andrea Brajković, Iva Mucalo, Toni Vidović, Mariana Martins Gonzaga, Do Nascimento, Antonija Balenović, Ino Protrka, Djenane Ramalho De Oliveira

Abstract

This study employed a mixed-method approach to enable the implementation of comprehensive medication management (CMM) services in Croatia's primary care setting. Drug therapy problems (DTPs) and factors associated with their occurrence were determined in patients with chronic diseases from January 2018 to April 2019. The pre-implementation stage established the foundations for the early implementation stage, in which the practice was set up, the patients' recruitment initiated and various challenges identified. During the study period, 86 patients were recruited for CMM provision. Overall, 2.8 DTPs (± 1.6) per patient were identified and the majority (96.2 %) presented with at least one DTP. Multiple regression analysis showed that type 2 diabetic patients (p = 0.025) and patients using five or more medications (p = 0.011) should be prioritized to receive CMM services as potentially they have a higher number of DTPs, and could, therefore, obtain a greater benefit from the service.

Keywords: comprehensive medication management services; drug therapy problems; implementation stage; pharmaceutical care; primary care; risk factors.

References

REFERENCES

    1. 1. T. McInnis, L. Strand and C. E. Webb, Integrating Comprehensive Medication Management to Optimize Patient Outcomes, Resour. Guid. (2012) A-26.
    1. 2. Institute of Medicine, Informing the Future: Critical Issues in Health: Fourth Edition, The National Academies Press, Washington DC 2007;
    1. 3. OECD/EU, Health at a Glance: Europe 2018: State of Health in the EU Cycle, OECD Publishing, Paris/EU, Brussels 2018;
    1. 4. World Health Organization, Noncommunicable diseases key facts, June 2018; access date April 29, 2019.
    1. 5. J. H. Watanabe, T. McInnis and J. D. Hirsch, Cost of Prescription Drug–Related Morbidity and Mortality, Ann. Pharmacother.52 (2018) 829-837;
    1. 6. F. R. Ernst and A. J. Grizzle, Drug-related morbidity and mortality: Updating the cost-of-illness model, J. Am. Pharm. Assoc.41 (2001) 192-199;
    1. 7. J. A. Johnson and J. L. Bootman, Drug-related morbidity and mortality and the economic impact of pharmaceutical care, Am. J. Health-Syst. Pharm.54 (1997) 554-558;
    1. 8. K. Wiedenmayer, R. S. Summers; C. A. Mackie, A. G. S. Gous, M. Everard and D. Tromp, Developing pharmacy practice – A focus on patient care, World Health Organization and International Pharmaceutical Federation, Geneva and The Hague 2006; access date April 29, 2019.
    1. 9. R. J. Cipolle, L. M. Strand and P. C. Morley, Pharmaceutical Care Practice: The Patient-Centered Approach to Medication Management, 3rd ed., The McGraw-Hill Companies, New York 2012.
    1. 10. Public Law, 117 STAT. 2066, PUBLIC LAW 108–173—DEC. 8, 2003, The Medicare Prescription Drug, Improvement, and Modernization Act of 2003, December 2003; access date April 29, 2019.
    1. 11. I. Torjesen, More than 400 pharmacists will be recruited to GP surgeries by next year, BMJ351 (2015) Article ID h6167 (2 pages);
    1. 12. Australian Medical Association, Analysis of non-dispensing pharmacists in general practice clinics, Deloitte Access Economics, Sydney 2015; access date April 29, 2019.
    1. 13. L. Dolovich, K. Pottie, J. Kaczorowski, B. Farrell, Z. Austin, C. Rodriguez, K. Gaebel and C. Sellors, Integrating family medicine and pharmacy to advance primary care therapeutics, Clin. Pharmacol. Ther.83 (2008) 913-917;
    1. 14. S. de A. M. Mendonça, A. C. Melo, G. C. C. Pereira, D. M. de S. S. dos Santos, E. B. Grossi, M. do C. V. B. Sousa, D. R. de Oliveira and A. C. Soares, Clinical outcomes of medication therapy management services in primary health care, Braz. J. Pharm. Sci.52 (2016) 365-373;
    1. 15. A. O. M. Mourão, W. R. Ferreira, M. A. P. Martins, A. M. M. Reis, M. R. G. Carrillo, A. G. Guimarães and L. S. Ev, Pharmaceutical care program for type 2 diabetes patients in Brazil: A randomised controlled trial, Int. J. Clin. Pharm.35 (2013) 79-86;
    1. 16. G. C. B. de Oliveira, M. R. Alves and D. R. de Oliveira, Action Research as a Tool for Transformation of the Pharmacist’s Praxis in Primary Care, Int. J. Pharm. Pharm. Sci.9 (2017) 180-185;
    1. 17. L. M. Strand, R. J. Cipolle, P. C. Morley and M. J. Frakes, The impact of pharmaceutical care practice on the practitioner and the patient in the ambulatory practice setting: twenty-five years of experience, Curr. Pharm. Des.10 (2004) 3987-4001;
    1. 18. D. R. de Oliveira, A. R. Brummel and D. B. Miller, Medication therapy management: 10 years of experience in a large integrated health care system, J. Manag. Care Spec Pharm.16 (2010) 185-195;
    1. 19. D. Rao, A. Gilbert, L. M. Strand and R. J. Cipolle, Drug therapy problems found in ambulatory patient populations in Minnesota and South Australia, Pharm. World Sci.29 (2007) 647-654;
    1. 20. L. G. Planas, K. M. Crosby, K. D. Mitchell and K. C. Farmer, Evaluation of a hypertension medication therapy management program in patients with diabetes, J. Am. Pharm. Assoc.49 (2009) 164-170;
    1. 21. A. Brummel and A. M. Carlson, Comprehensive Medication Management and Medication Adherence for Chronic Conditions, J. Manag. Care Spec. Pharm.22 (2016) 56-62;
    1. 22. C. W. Cranor, B. A. Bunting and D. B. Christensen, The Asheville Project: Long-term clinical and economic outcomes of a community pharmacy diabetes care program, J. Am. Pharm. Assoc.43 (2003) 173-184;
    1. 23. B. J. Isetts, S. W. Schondelmeyer, M. B. Artz, L. a Lenarz, A. H. Heaton, W. B. Wadd, L. M. Brown and R. J. Cipolle, Clinical and economic outcomes of medication therapy management services: the Minnesota experience, J. Am. Pharm. Assoc.48 (2008) 203-214;
    1. 24. K. B. Detoni, I. V Oliveira, M. M. G. Nascimento, T. R. Caux, M. R. Alvares and D. R. de Oliveira, Impact of a medication therapy management service on the clinical status of patients with chronic obstructive pulmonary disease, Int. J. Clin. Pharm.39 (2016) 95-103;
    1. 25. P. R. Obreli-Neto, S. Marusic, C. M. Guidoni, A. de O. Baldoni, R. D. Renovato, D. Pilger, R. K. N. Cuman and L. R. L. Pereira, Economic evaluation of a pharmaceutical care program for elderly diabetic and hypertensive patients in primary health care: a 36-month randomized controlled clinical trial, J. Manag. Care Spec. Pharm.21 (2015) 66-75;
    1. 26. H. Schultz, S. M. Westberg, D. R. de Oliveira and A. Brummel, Patient-perceived value of Medication Therapy Management (MTM) services: a series of focus groups, Innov. Pharm.3 (2012) Article ID 96 (8 pages);
    1. 27. D. G. Garrett and L. A. Martin, The Asheville Project: Participants’ perceptions of factors contributing to the success of a patient self-management diabetes program, J. Am. Pharm. Assoc.43 (2003) 185-190;
    1. 28. O. A. Abdela, A. S. Bhagavathula, H. Getachew and Y. Kelifa, Risk factors for developing drug-related problems in patients with cardiovascular diseases attending Gondar University Hospital, Ethiopia, J. Pharm. BioAllied Sci.8 (2016) 289-295;
    1. 29. Y. L. Niriayo, K. Kumela, T. D. Kassa and M. T. Angamo, Drug therapy problems and contributing factors in the management of heart failure patients in Jimma University Specialized Hospital, Southwest Ethiopia, PLoS One13 (2018) Article ID e0206120 (14 pages);
    1. 30. S. I. Al-Azzam, K. H. Alzoubi, S. Aburuz and Q. Alefan, Drug-related problems in a sample of out-patients with chronic diseases: A cross-sectional study from Jordan, Ther. Clin. Risk Manag.12 (2016) 233-239;
    1. 31. O. Urbina, O. Ferrández, S. Luque, S. Grau, S. Mojal, R. Pellicer, M. Riu, E. Salas and J. Comin-Colet, Patient risk factors for developing a drug-related problem in a cardiology ward, Ther. Clin. Risk Manag.11 (2014) 9-15;
    1. 32. K. Lewin, Field Theory In Social Science; Selected Theoretical Papers (D. Cartwright, Ed.). Harper & Brothers Publisher New York, New York 1976.
    1. 33. C. Blanchard, M. Livet, C. Ward, L. Sorge, T. D. Sorensen and M. R. McClurg, The active implementation frameworks: A roadmap for advancing implementation of comprehensive medication management in primary care, Res. Social Adm. Pharm.13 (2017) 922-929;
    1. 34. M. Livet, C. Blanchard, T. D. Sorensen and M. R. McClurg, An implementation system for medication optimization: Operationalizing comprehensive medication management delivery in primary care, J. Am. Coll. Clin. Pharm.1 (2018) 14-20;
    1. 35. Health Centre Zagreb – Centre and MCS Grupa d.o.o., PRO ( PRO), access date April 29, 2019.
    1. 36. A. Bowling, Research Methods in Health: investigating health and health services, 3rd ed., The McGraw-Hill Companies, New York 2009, pp. 222-223.
    1. 37. D. L. Pestka, L. A. Sorge, M. R. McClurg and T. D. Sorensen, The Philosophy of Practice for Comprehensive Medication Management: Evaluating Its Meaning and Application by Practitioners, Pharmacotherapy38 (2018) 69-79;
    1. 38. The Agency for Medicinal Products and Medical Devices, Croatia, Medicinal Products Database, 2019; access date April 20, 2019.
    1. 39. J. T. DiPiro, R. L. Talbert, G. C. Yee, G. R. Matzke, B. G. Wells, L. M. Posey, Pharmacotherapy A Pathophysiologic Approach, 10th ed., McGraw-Hill Education, New York 2017.
    1. 40. D. L. Krinsky, S. P. Ferreri, B. Hemstreet, A. L. Hume, G. D. Newton, C. J. Rollins, K. J. Tietze, Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 19th ed., American Pharmacists Association, Washington, DC 2018;
    1. 41. UpToDate, Post, TW (Ed), UpToDate, Waltham, MA 2019; access date April 20, 2019.
    1. 42. P. A. do Amaral, S. de A. M. Mendonça, D. R. de Oliveira, L. J. Peloso, R. D. S. Pedroso and M. Â. Ribeiro, Impact of a medication therapy management service offered to patients in treatment of breast cancer, Braz. J. Pharm. Sci.54 (2018) Article ID e00221 (12 pages);
    1. 43. D. R. de Oliveira, Pharmaceutical care uncovered: an ethnographic study of pharmaceutical care practice, University of Minnesota, Minneapolis 2003.
    1. 44. S. de A. M. Mendonça, E. L. de Freitas and D. R. de Oliveira, Competencies for the provision of comprehensive medication management services in an experiential learning project, PLoS One12 (2017) e0185415 (14 pages);
    1. 45. E. L. de Freitas and D. R. de Oliveira, Critical thinking in the context of clinical practice: The need to reinvent pharmacy education, Rev. Port. Educ.28 (2015) 231-250;
    1. 46. M. Rosenthal, Z. Austin and R. T. Tsuyuki, Are pharmacists the ultimate barrier to pharmacy practice change?, Can. Pharm. J.143 (2010) 37-42;
    1. 47. M. Â. Ribeiro, S. A. M. Araújo, M. Mendonça, A. F. R. Filardi, A. C. Y. dos Anjos and D. R. de Oliveira, Implementation and systematization of a comprehensive medication management (CMM) service delivered to women with breast cancer, Asian J. Pharm. Clin. Res.11 (2018) 228-235;
    1. 48. A. B. Blondal, S. K. Sporrong and A. B. Almarsdottir, Introducing Pharmaceutical Care to Primary Care in Iceland - An Action Research Study, Pharmacy (Basel)5 (2017) 23 (11 pages);
    1. 49. L. S. Nørgaard and E. W. Sørensen, Action research methodology in clinical pharmacy: how to involve and change, Int. J. Clin. Pharm.38 (2016) 739-745;
    1. 50. T. D. Sorensen, D. L. Pestka, A. R. Brummel, D. J. Rehrauer and M. J. Ekstrand, Seeing the forest through the trees: improving adherence alone will not optimize medication use, J. Manag. Care Spec. Pharm. 22 (2016) 598-604;

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner